Abstract:Spinal cord injury (SCI) is a devastating type of neurological disorder of the central nervous system (CNS) with high mortality and disability. The pathological processes of SCI can usually be described as two stages, namely, primary and acute secondary injuries. Secondary injury produces more significant exacerbations of the initial injury. Among all the mechanisms of secondary damage, infection and inflammatory responses, as the principle culprits in initiating the second phase of SCI, can greatly contribute to the severity of SCI and numerous sequelae after SCI. Therefore, effectively antagonizing pro-inflammatory responses may be a promising treatment strategy to facilitate functional recovery after SCI. Olfactory ensheathing cells (OECs), a unique type of glial cells, have increasingly become potential candidates for cell-based therapy in the injured CNS. Strikingly, there is growing evidence that the mechanisms underlying the anti-inflammatory role of OECs are associated with the immune properties and secretory functions of these cells responsible for anti-neuroinflammation and immunoregulatory effects, leading to maintenance of the internal microenvironment. Accordingly, a more profound understanding of the mechanism of OEC immunological functions in the treatment of SCI would be beneficial to improve the therapeutic clinical applications of OECs for SCI. In this review, we mainly summarize recent research on the cellular and molecular immune attributes of OECs. The unique biological functions of these cells in promoting neural regeneration are discussed in relation of the development of novel therapies for CNS injury.

Good or evil——Role of T lymphocytes in the treatment of spinal cord injury

Inflammation & apoptosis in spinal cord injury.

Current Knowledge of Microglia in Traumatic Spinal Cord Injury

A Brief Summary of Current Therapeutic Strategies for Spinal Cord Injury

New Insights into the Biological Roles of Immune Cells in Neural Stem Cells in Post-Traumatic Injury of the Central Nervous System

Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.

Role of inflammation in neurological damage and regeneration following spinal cord injury and its therapeutic implications

Spinal cord injury: T cells to the rescue?

Inflammatory Response to Spinal Cord Injury and Its Treatment

TGF‐β signaling pathway in spinal cord injury: Mechanisms and therapeutic potential

The Immunological Roles of Olfactory Ensheathing Cells in the Treatment of Spinal Cord Injury

Research Progress on Treating Spinal Cord Injury by Modulating the Phenotype of Microglia

Recent progress and challenges in the treatment of spinal cord injury

The immune microenvironment and tissue engineering strategies for spinal cord regeneration

Spinal cord injury: molecular mechanisms and therapeutic interventions

Role of dendritic cells in spinal cord injury

Effects of astrocytes and microglia on neuroinflammation after spinal cord injury and related immunomodulatory strategies

Neuroinflammation and Scarring After Spinal Cord Injury: Therapeutic Roles of MSCs on Inflammation and Glial Scar

Experimental and Clinical Advances in Immunotherapy Strategies for Spinal Cord Injury Target on MAIs and Their Receptors.

Mitigating sTNF/TNFR1 activation on VGluT2+ spinal cord interneurons improves immune function after mid-thoracic spinal cord injury

Current Treatments after Spinal Cord Injury: Cell Engineering, Tissue Engineering, and Combined Therapies